Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Anastasios Kyriazoglou"'
Autor:
Angeliki Andrikopoulou, Eleni Zografos, Kleoniki Apostolidou, Anastasios Kyriazoglou, Alksistis-Maria Papatheodoridi, Maria Kaparelou, Konstantinos Koutsoukos, Michalis Liontos, Meletios-Athanasios Dimopoulos, Flora Zagouri
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGermline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond these mutations, germline or somatic aberrations in genes of the homologous recombi
Externí odkaz:
https://doaj.org/article/ad7a03d06b4e42429fb6213aad41062c
Autor:
Wen-Bin Ou, Meijun Z. Lundberg, Shuihao Zhu, Nacef Bahri, Anastasios Kyriazoglou, Liangliang Xu, Ting Chen, Adrian Mariño-Enriquez, Jonathan A. Fletcher
Publikováno v:
Oncogenesis, Vol 10, Iss 5, Pp 1-9 (2021)
Abstract Endometrial stromal sarcoma (ESS) is the second most common subtype of uterine mesenchymal cancer, after leiomyosarcoma, and oncogenic fusion proteins are found in many ESS. Our previous studies demonstrated transforming properties and diagn
Externí odkaz:
https://doaj.org/article/895d9a80b1a14ec68af5a84662df19cf
Autor:
Maria Kaparelou, Michalis Liontos, Pelagia Katsimbri, Aggeliki Andrikopoulou, Alikistis Papatheodoridi, Anastasios Kyriazoglou, Aristotelis Bamias, Flora Zagouri, Meletios Athanasios Dimopoulos
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100953- (2022)
Background: Joint manifestations are ill-defined adverse events that were frequently reported of bevacizumab in ovarian cancer patients. The aim of this study is to describe the incidence and severity of joint manifestations among bevacizumab treated
Externí odkaz:
https://doaj.org/article/fdaca4108a914205b377c4cdbe44e098
Autor:
Anastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, Flora Zagouri, Kostantinos Koutsoukos, Giorgos Tsironis, Anna Tsiara, Maria Kaparelou, Roubini Zakopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Irene Papaspyrou, Alexandros Rodolakis, Aristotelis Bamias, Meletios Athanasios Dimopoulos
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Uterine sarcomas consist a heterogeneous group of mesenchymal gynecological malignancies with unclear therapeutic recommendations and unspecific but poor prognosis, since they usually metastasize and tend to recur very often, even
Externí odkaz:
https://doaj.org/article/b70e41c0d8b64b5b8493234644bee22b
Autor:
Panagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, Ioannis Kotsantis, Anastasios Kyriazoglou, George Kavourakis, Roubini Zakopoulou, Ioannis Chatzidakis, Maria Anastasiou, Maria Prevezanou, Carlo Resteghini, Lisa Licitra, Cristiana Bergamini, Elena Colombo, Francesca Caspani, Nerina Denaro, Stefania Vecchio, Pierluigi Bonomo, Maria Cossu Rocca, Federica Bertolini, Daris Ferrari, Amanda Psyrri, Paolo Bossi
Publikováno v:
Cells, Vol 11, Iss 1, p 32 (2021)
Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions. Real-world data with immunotherapy from nonendemic regions are limited. Methods: we collected data from patients with recurrent/metast
Externí odkaz:
https://doaj.org/article/07b0958aff5f4503989c97d0a1e5d398
Autor:
Angeliki Andrikopoulou, Oraianthi Fiste, Kleoniki Apostolidou, Efthymia Skafida, Christos Markellos, Michalis Liontos, Anastasios Kyriazoglou, Meletios-Athanasios Dimopoulos, Flora Zagouri
Publikováno v:
Medical Sciences, Vol 9, Iss 2, p 42 (2021)
Background: Aromatase inhibitors (AIs) are associated with musculoskeletal pain in one third (20–47%) of breast cancer patients. Recently, CDK4/6 inhibitors have emerged as a new therapeutic approach in hormone receptor (HR)-positive breast cancer.
Externí odkaz:
https://doaj.org/article/b72bcc53044e41cf8c700e7f52164f57
Publikováno v:
ESMO Open, Vol 4, Iss 3 (2019)
Phyllodes tumours of the breast are rare mesenchymal tumours with differential malignant potential. Treatment of choice is radical excision with negative margins. Radiation therapy has shown controversial results in small series. Chemotherapy in the
Externí odkaz:
https://doaj.org/article/fb6464a3a31046b3836079b07eb88991
Autor:
Anastasios Kyriazoglou, Efhtymios Dimitriadis, Luiza Mahaira, John Kotsantis, Vasileios Kouloulias, Vasileios Kontogeorgakos, Amanda Psyrri, Georgios Agrogiannis
Publikováno v:
Cancer Genetics. :93-96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14df90b8135e9b88836dc11b535ec5f8
https://doi.org/10.1016/j.cancergen.2022.09.012
https://doi.org/10.1016/j.cancergen.2022.09.012
Autor:
Anastasios Kyriazoglou, Pieter Jespers, Vincent Vandecavaye, Olivier Mir, Bernd Kasper, Zsuzsanna Papai, Jean-Yves Blay, Antoine Italiano, Facundo Zaffaroni, Saskia Litière, Axelle Nzokirantevye, Patrick Schöffski
Publikováno v:
Acta Oncologica. 61:663-668
Gastrointestinal stromal tumors (GISTs) are malignant mesenchymal tumors arising in the gastrointestinal tract. Their systemic treatment is based on the use of tyrosine kinase inhibitors (TKIs) with imatinib, sunitinib, and regorafenib being the pref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ea0a9aad0fbd3a910f014565e9e053
https://doi.org/10.1080/0284186x.2022.2068967
https://doi.org/10.1080/0284186x.2022.2068967
Autor:
ANASTASIOS KYRIAZOGLOU, ANNA-MARIA KORAKITI, ALKISTIS-MARIA PAPATHEODORIDI, KLEONIKI APOSTOLIDOU, AFRODITI NONNI, ELENI ZOGRAFOS, GARYFALIA BLETSA, DIMITRIS TSAKOGIANNIS, MELETIOS-ATHANASIOS DIMOPOULOS, FLORA ZAGOURI
Publikováno v:
In Vivo
Background/Aim: The Hippo pathway is a molecular pathway recently associated with tumorigenesis, metastasis, and drug resistance. Pregnancy-associated breast cancer (PABC) is the most common malignancy diagnosed during gestation; however, the molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de73800b884af102875b3196dffc38b9
https://doi.org/10.21873/invivo.13027
https://doi.org/10.21873/invivo.13027